Archives of Digestive Disorders

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-1518081136

Mini Review - Archives of Digestive Disorders (2023) Volume 5, Issue 3

Gut microbiota dysbiosis and its implications in digestive disorders: current perspectives.

Michael Kummer *

Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA

*Corresponding Author:
Michael Kummer
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA

Received: 03- Apr-2023, Manuscript No. AAADD-23-100513; Editor assigned: 04-Apr-2023, PreQC No. AAADD-23-100513(PQ); Reviewed19- Apr-2023, QC No. AAADD-23-100513; Revised:22-Apr-2023, Manuscript No. AAADD-23-100513(R); Published: 02-May-2023, DOI:10.35841/aaadd-5.3.142

Citation: Kummer M. Gut microbiota dysbiosis and its implications in digestive disorders: Current perspectives. Arch Dig Disord. 2023;5(3):142

Visit for more related articles at Archives of Digestive Disorders


Gut microbiota, Dysbiosis, Digestive disorders, Gut-brain axis, Inflammation


The human gastrointestinal tract harbors a vast and diverse community of microorganisms, collectively known as the gut microbiota. Composed of bacteria, viruses, fungi, and archaea, the gut microbiota is estimated to contain trillions of microbial cells, outnumbering human cells by a factor of 10 to 1. This microbial ecosystem has coevolved with the human host and performs a wide range of essential functions, including nutrient metabolism, immune modulation, and protection against pathogens. However, disturbances in the composition and function of the gut microbiota, termed dysbiosis, have emerged as a key factor in the pathogenesis of various digestive disorders [1].

Several studies have reported associations between gut microbiota dysbiosis and digestive disorders such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and gastroesophageal reflux disease (GERD). In IBD, characterized by chronic inflammation of the gastrointestinal tract, alterations in the gut microbiota composition have been observed, with a reduction in beneficial bacteria and an expansion of potentially harmful species. Similarly, patients with IBS exhibit alterations in gut microbial diversity and an imbalance between beneficial and pathogenic bacteria [2].

Furthermore, emerging evidence suggests that dysbiosis may also contribute to the development of GERD, a condition characterized by the reflux of stomach acid into the esophagus. The mechanisms underlying the association between gut microbiota dysbiosis and digestive disorders are multifactorial. The gut microbiota communicates bidirectionally with the host through the gut-brain axis, a complex network involving the central nervous system, the enteric nervous system, and the gut microbiota [3].

Disruptions in this axis can lead to alterations in gut motility, visceral hypersensitivity, and aberrant immune responses, all of which are implicated in digestive disorders. Dysbiosis-induced inflammation is another key mechanism linking gut microbiota dysbiosis to digestive disorders. Imbalances in the gut microbiota can trigger an excessive immune response, resulting in chronic inflammation and tissue damage within the gastrointestinal tract. In light of these findings, strategies aimed at modulating the gut microbiota have gained considerable attention as potential therapeutic interventions for digestive disorders [4].

Probiotics, which are live microorganisms with health benefits, have shown promise in restoring gut microbiota balance and alleviating symptoms in some patients with IBD and IBS. Additionally, fecal microbiota transplantation, a procedure involving the transfer of fecal material from a healthy donor to a recipient, has emerged as an effective treatment for recurrent Clostridium difficile infection, highlighting the therapeutic potential of manipulating the gut microbiota [5].


In conclusion, gut microbiota dysbiosis plays a pivotal role in the development and progression of various digestive disorders. Understanding the intricate relationship between the gut microbiota and digestive health offers new perspectives for diagnosis, prevention, and treatment of these conditions. Further research is needed to elucidate the specific mechanisms underlying the gut microbiota-digestive disorder interactions and to develop targeted therapeutic strategies for restoring gut microbiota homeostasis. By harnessing the therapeutic potential of the gut microbiota, we can aspire to improve the outcomes and quality of life for individuals suffering from digestive disorders.


  1. Bajaj JS, Heuman DM, Hylemon PB, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol. 2014;60(5):940-947
  2. Indexed at, Google Scholar, Cross Ref

  3. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59-65.
  4. Indexed at, Google Scholar, Cross Ref

  5. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174-180.
  6. Indexed at, Google Scholar, Cross Ref

  7. Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65(2):330-339.
  8. Indexed at, Google Scholar, Cross Ref

  9. 5. De Vos WM, De Vos EA. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev. 2012;70:S45-S56.
  10. Indexed at, Google Scholar, Cross Ref

Get the App